Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
FBIO:NASDAQ
Fortress Biotech Inc
$2.33
+4.48%
(+0.100) 1D
$2.37
+1.72% (+0.040)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBIO...
Open
$2.24
High
$2.34
Low
$2.23
Mkt. cap
75.03M
Avg. vol.
465.63K
Volume
194.77K
52-wk high
$4.53
52-wk low
$1.54
EPS
-$0.07
Beta
1.44
Shares outstanding
32.20M
No. of employees
78
News stories
From sources across the web
Profile
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
About Fortress Biotech Inc
CEOLindsay Rosenwald
Employees78
Founded2006
HeadquartersBay Harbor Islands, Florida, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
13.14M
16.41M
17.63M
16.08M
Cost of goods sold
8.73M
13.06M
5.96M
5.07M
Cost of revenue
8.73M
13.06M
5.96M
5.07M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.66M
38.76M
17.42M
14.73M
Operating expense
26.73M
39.82M
18.48M
15.80M
Total operating expenses
35.46M
52.89M
24.44M
20.87M
Operating income
-22.32M
-36.47M
-6.81M
-4.79M
Other non operating income
-59.00K
-412.00K
32.74M
5.00K
EBT including unusual items
-24.69M
-11.65M
8.85M
-6.21M
EBT excluding unusual items
-24.69M
-38.78M
23.93M
-6.19M
Income tax expense
-
-
26.00K
-816.00K
Effective tax rate
-
-
0.29%
13.13%
Other operating expenses
-
-
-
-
Net income
-10.58M
15.49M
5.85M
-3.94M
Net profit margin
-80.55%
94.35%
33.18%
-24.49%
Earnings per share
-0.48
-0.51
-
-
Interest and investment income
490.00K
622.00K
736.00K
637.00K
Interest expense
-2.80M
-2.52M
-2.74M
-2.04M
Net interest expenses
-2.32M
-1.90M
-2.01M
-1.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.13M
-35.32M
-5.65M
-3.63M
Gain or loss from assets sale
-
-27.13M
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more